- PARP Inhibitors: Improving Outcomes in Metastatic Prostate Cancer.
- Nelson R.
- Medscape. 2022 Feb 22.
- Conference report
- Free Full Text
- PARP inhibitors for metastatic castration-resistant prostate cancer: Biological rationale and current evidence.
- Bienkowski M, Tomasik B, Braun M, Jassem J.
- Cancer Treat Rev. 2022 Feb 11;104:102359. doi: 10.1016/j.ctrv.2022.102359. Epub ahead of print.
- PMID: 35190335
- PubMed abstract
- Source abstract
- Review